Home » Authors » Jim Stommen

Jim Stommen

Articles

ARTICLES

McClellan sees CMS, industry partnering in innovation push

March 7, 2005

Panel: In order to avoid pitfalls, start reimbursement drive early

March 4, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 6, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 4, 2005

Growing convergence of technologies interests clinicians, industry

June 1, 2004

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

Innovative technologies from smaller cardio firms stir interest

March 1, 2002

It's no MIRACLE that new EP therapies are being ADOPTed

July 1, 2001

Big hitters, emerging firms tell their tales at Piper Jaffray gathering

March 1, 2000

View All Articles by Jim Stommen

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...